Singapore markets closed
Straits Times Index
3,272.72 +47.55 (+1.47%) S&P 500
5,010.60 +43.37 (+0.87%) Dow
38,239.98 +253.58 (+0.67%) Nasdaq
15,451.31 +169.30 (+1.11%) Bitcoin USD
66,096.98 +171.60 (+0.26%) CMC Crypto 200
1,421.23 +6.47 (+0.46%)
ABBV Jan 2025 165.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:32AM EDT. Market open.
| Previous close | 10.10 |
| Open | 10.10 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 165.00 |
| Expiry date | 2025-01-17 |
| Day's range | 10.10 - 10.10 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksAbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Investor focus is likely to be on the sales of AbbVie's (ABBV) blockbuster immunology drugs Rinvoq and Skyrizi when it reports first-quarter results.
ZacksEarnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksPharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
J&J (JNJ) posts mixed first-quarter 2024 results. Lilly's (LLY) tirzepatide meets key goals in late-stage studies for obstructive sleep apnea.
© 2024 Yahoo. All rights reserved.